title: Calcium antagonists: their role in neuroprotection.
authors.affiliation: SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, Essex, UK.
authors.forename: A J
authors.initials: AJ
authors.lastname: Hunter
mesh_terms: D000818:Animals; D002545:Brain Ischemia / Q000150:complications / Q000503:physiopathology*; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000494:pharmacology*; D015220:Calcium Channels / Q000145:classification / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000209:etiology / Q000503:physiopathology*; D004095:Dihydropyridines / Q000494:pharmacology; D005444:Flunarizine / Q000494:pharmacology; D006801:Humans; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000494:pharmacology*; D014700:Verapamil / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D002121:Calcium Channel Blockers; D015220:Calcium Channels; D004095:Dihydropyridines; D018696:Neuroprotective Agents; D014700:Verapamil; C052752:emopamil; D005444:Flunarizine